23 December 2020 · The availability of four teriparatide preparations (originator, two biosimilars and a generic version) in the UK market creates a potential for confusion in the prescribing,…
24 November 2020 · UPDATED AUTUMN 2020 to reflect legislation changes and UK availability of Flublok (QIVr) Following advice issued in Spring 2018 advising on the use of Patient…
21 October 2020 · This paper documents the actions and decision-making process of the National Homecare Medicines Committee (NHMC) and members of the National Clinical Homecare Association (NCHA) during…
16 October 2020 · Following the review of stability for cytotoxic drugs for the NHS tender, these monographs are designed to capture the information in a format that is…
16 October 2020 · Following the review of stability for cytotoxic drugs for the NHS tender, these monographs are designed to capture the information in a format that is…
16 October 2020 · Following the review of stability for cytotoxic drugs for the NHS tender, these monographs are designed to capture the information in a format that is…
12 August 2020 · Questions have been asked as to whether or not it is acceptable for a registered or unregistered healthcare professional (HCP) to prepare and/or administer contrast…
10 August 2020 · In response to the COVID-19 pandemic the Nursing and Midwifery Council (NMC), the Healthcare Professionals Council (HCPC) and the General Pharmaceutical Council (GPhC) have opened…
10 August 2020 · Questions are frequently asked around the use of Patient Group Direction (PGDs) use in End of Life Care (EoLC). As with any other patient pathway…
25 March 2020 · SPS and the Faculty of Sexual and Reproductive Health (FSRH), with the support of specialist stakeholders working within clinical practice, have produced PGD templates for…